ReviewTargeted oncology2019

Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.

Sarah Sammons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.